Disposition of 5-ASa by olsalazine (Dipentum) and mesalazine (Asacol) in patients with ulcerative colitis in remission

被引：0
|
作者：
Archimandritis, A
Hatzis, G
Konstandinidis, A
Paraskeva, K
Tjivras, M
Skandalis, N
机构：
[1] UNIV ATHENS, LAIKO GEN HOSP,SCH MED,DEPT PATHOPHYSIOL, GASTROENTEROL SECT, ATHENS, GREECE
[2] GEN STATE HOSP ATHENS, GASTROENTEROL CLIN, ATHENS, GREECE
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A924 / A924
页数：1
相关论文
共 50 条
  • [31] PERICARDITIS CONSECUTIVE TO MESALAZINE TREATMENT (5-ASA)
    DESMEULES, J
    VOGT, N
    LOIZEAU, S
    ANGELILLOSCHERRER, A
    DAYER, P
    THERAPIE, 1994, 49 (04): : 359 - 361
  • [32] COMPARISONS OF OLSALAZINE AND MESALAZINE IN PREVENTION OF RELAPSE IN ULCERATIVE-COLITIS
    GAIT, JE
    SIMERL, NA
    LANCET, 1992, 340 (8817): : 486 - 487
  • [33] MESALAZINE VERSUS OLSALAZINE FOR PROPHYLAXIS OF ULCERATIVE-COLITIS RELAPSE
    RECORD, CO
    MACRAE, K
    LANCET, 1992, 340 (8833): : 1468 - 1468
  • [34] Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine
    Karamanolis, DG
    Papatheodoridis, GV
    Xourgias, V
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (11) : 1083 - 1088
  • [35] Predictors of 5-ASA prescription persistence during the acute phase in patients with ulcerative colitis
    Kane, S.
    Magowan, S.
    Accortt, N.
    Diana, B.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S17 - S17
  • [36] MESALAZINE (5ASA) IS AS EFFECTIVE AS SULFASALAZINE-(SZ) IN MAINTENANCE OF REMISSION IN ULCERATIVE COLITIS-(UC)
    RACHMILEWITZ, D
    GASTROENTEROLOGY, 1988, 94 (05) : A362 - A362
  • [37] Predictors of 5-asa prescription persistence during the chronic phase in patients with ulcerative colitis
    Kane, S.
    Magowan, S.
    Accortt, N.
    Brixner, D.
    GUT, 2008, 57 : A119 - A120
  • [38] Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX® with Asacol®
    Prantera, C.
    Kohn, A.
    Campieri, M.
    Caprilli, R.
    Cottone, M.
    Pallone, F.
    Savarino, V.
    Sturniolo, G. C.
    Vecchi, M.
    Ardia, A.
    Bellinvia, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (09) : 908 - 918
  • [39] 5-AMINOSALICYLIC ACID (5-ASA) ENEMAS IN REFRACTORY DISTAL ULCERATIVE-COLITIS (UC) - MAINTENANCE OF REMISSION
    GUARINO, J
    BERK, T
    FRIEDMAN, LS
    GASTROENTEROLOGY, 1986, 90 (05) : 1441 - 1441
  • [40] Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis
    Kruis, W
    Brandes, JW
    Schreiber, S
    Theuer, D
    Krakamp, B
    Schutz, E
    Otto, P
    Lorenz-Mayer, H
    Ewe, K
    Judamaier, G
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 707 - 715
12345